Welcome to KEMGEN

Transforming Patient Care & Empowering Healthcare with Biosimilars

Kemgen Biologics is an Indian operating company with the aim of supplying high quality, safe and affordable biologics in supporting patients in need across the Southern part of the Nation. Discover More About Us
One stop solution for bone health needs.

We are committed to strengthening health care with the introduction of novel drugs to find therapeutic solutions and better outcomes which in turn create value for patients. Our products are marketed not just to cure ailments but also to make a significant difference.

Contact Us
Why Biosimilars
FDA Approved

Biosimilars are biologic medicines that are remarkably comparable to previously FDA‐approved biologic products or the reference medicine.

Complex Molecules

Biosimilars are large and generally complex molecules and are produced from living organisms.

Clinical Studies

Biosimilars are approved by FDA after rigorous clinical studies and assessments.



Safety and Effectiveness

Biosimilars have no clinically meaningful differences in terms of safety and effectiveness from the reference product. Only certain minor modifications in the clinically inactive components

Value to Health Care

Biosimilars are rapidly expanding in a way to bring value to Health Care. Biosimilars provide lower cost treatment option, reducing the economic burden, making these treatments.

Safe and Effective Treatment Options

Biosimilars are safe and effective treatment options for many ailments including chronic skin and bowel diseases, arthritis, kidney conditions, and cancer.